<< Read Full Article
<< Read Full Article
Health stocks, such as Tercica(TRCA Quote), neared the long weekend on the uptick refreshed by regulatory approvals and clinical advancements Friday.
Tercica shares rose 1.5% to $6.64 on news partner Ipsen received Food and Drug Administration approval of its Somatuline Depot, a long-term treatment of acromegaly, a disorder caused by overproduction of growth hormone.
The drug will compete with Novartis'(NVS Quote) Sandostatin LAR Depot. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet